Prevention of Cisplatin-Induced Acute Kidney Injury: A Systematic Review and Meta-Analysis.
Journal
Drugs
ISSN: 1179-1950
Titre abrégé: Drugs
Pays: New Zealand
ID NLM: 7600076
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
pubmed:
21
8
2019
medline:
6
2
2020
entrez:
21
8
2019
Statut:
ppublish
Résumé
Cisplatin-induced acute kidney injury (CIA) is a serious adverse event that affects 20-40% of exposed patients, despite any implemented precaution to avoid it. The aim of this work was therefore to identify a relevant nephroprotective method for CIA. We searched Pubmed, Embase, and Web of Science from 1 January 1978 to 1 June 2018, without language restriction. All studies (observational and interventional) assessing a CIA prevention method for adults receiving at least one course of cisplatin were eligible. The primary outcome was acute nephrotoxicity, as defined by the AKI-KDIGO classification (2012). The odds ratio and corresponding 95% confidence interval were used to assess the associations. We used narrative synthesis in case of heterogeneity regarding intervention, population, or outcome. When possible, a random-effects model was used to pool studies. The heterogeneity between studies was quantified (I Within 4520 eligible studies, 51 articles fulfilling the selection criteria were included in the review, assessing 21 different prevention methods. A meta-analysis could only be performed on the 15 observational studies concerning magnesium supplementation (1841 patients), and showed a significant nephroprotective effect for all combined grades of CIA (OR 0.24, [0.19-0.32], I While no method of prevention had so far demonstrated its indisputable efficacy, our results highlight the potential protective effect of magnesium supplementation on cisplatin-induced acute nephrotoxicity. This study is registered in PROSPERO, CRD42018090612.
Identifiants
pubmed: 31429065
doi: 10.1007/s40265-019-01182-1
pii: 10.1007/s40265-019-01182-1
doi:
Substances chimiques
Cisplatin
Q20Q21Q62J
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1567-1582Références
Ann Oncol. 1999 Jun;10(6):693-700
pubmed: 10442192
Anticancer Drugs. 2000 Jan;11(1):1-6
pubmed: 10757556
Invest New Drugs. 2000 Aug;18(3):281-9
pubmed: 10958599
Int J Clin Pharmacol Ther. 2001 Mar;39(3):121-5
pubmed: 11396752
Ann Oncol. 2001 Aug;12(8):1151-5
pubmed: 11583199
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
J Nutr Health Aging. 2002;6(2):147-53
pubmed: 12166371
Cancer Chemother Pharmacol. 2003 Jul;52(1):13-8
pubmed: 12719883
Semin Nephrol. 2003 Sep;23(5):460-4
pubmed: 13680535
Proc R Soc Med. 1965 May;58:295-300
pubmed: 14283879
Nature. 1965 Feb 13;205:698-9
pubmed: 14287410
Gan To Kagaku Ryoho. 1992 Jul;19(8 Suppl):1113-20
pubmed: 1514821
Eur J Cancer. 2004 Jul;40(11):1713-23
pubmed: 15251161
J Am Soc Nephrol. 2005 Feb;16(2):452-8
pubmed: 15590762
Nat Rev Drug Discov. 2005 Apr;4(4):307-20
pubmed: 15789122
Fam Med. 2005 May;37(5):360-3
pubmed: 15883903
J Am Soc Nephrol. 2005 Nov;16(11):3365-70
pubmed: 16177006
Stat Med. 2006 Oct 30;25(20):3443-57
pubmed: 16345038
Am J Med Sci. 2007 Aug;334(2):115-24
pubmed: 17700201
Kidney Int. 2008 Mar;73(5):538-46
pubmed: 18160961
Kidney Int. 2008 May;73(9):994-1007
pubmed: 18272962
Cancer Chemother Pharmacol. 2008 May;61(6):903-9
pubmed: 18317762
Clin Pharmacol Ther. 2008 Nov;84(5):559-62
pubmed: 18401339
Eur J Cancer. 2008 Nov;44(17):2608-14
pubmed: 18796350
J Hum Genet. 2009 Jan;54(1):40-6
pubmed: 19158817
Pharmacogenomics J. 2009 Apr;9(2):127-36
pubmed: 19172157
Clin Exp Nephrol. 2009 Dec;13(6):578-84
pubmed: 19629622
J Oncol Pharm Pract. 2010 Sep;16(3):167-71
pubmed: 19759050
J Am Soc Nephrol. 2010 Feb;21(2):345-52
pubmed: 20019168
Dalton Trans. 2010 Sep 21;39(35):8113-27
pubmed: 20593091
J Craniomaxillofac Surg. 2011 Mar;39(2):91-2
pubmed: 21145753
BMJ. 2011 Jul 22;343:d4002
pubmed: 21784880
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
Cancer. 2012 Oct 1;118(19):4785-94
pubmed: 22282373
Nutr Rev. 2012 Mar;70(3):153-64
pubmed: 22364157
Food Chem Toxicol. 2012 Jul;50(7):2289-93
pubmed: 22525860
Clin Exp Nephrol. 2012 Dec;16(6):843-51
pubmed: 22569819
Oncology. 2012;82(6):354-9
pubmed: 22722365
J Thorac Dis. 2012 Dec;4(6):562-8
pubmed: 23205279
Gan To Kagaku Ryoho. 2013 Jun;40(6):743-7
pubmed: 23863650
Ren Fail. 2014 Feb;36(1):5-8
pubmed: 24059271
Oncology. 2013;85(6):364-9
pubmed: 24335484
Int Urol Nephrol. 2014 Jul;46(7):1367-73
pubmed: 24448757
Jpn J Clin Oncol. 2014 Apr;44(4):346-54
pubmed: 24503028
J Res Med Sci. 2013 Jul;18(7):626-7
pubmed: 24516499
Ann Pharmacother. 2014 Apr 28;48(7):863-869
pubmed: 24778426
Am J Physiol Renal Physiol. 2014 Aug 15;307(4):F369-84
pubmed: 24944268
PLoS One. 2014 Jul 14;9(7):e101902
pubmed: 25020203
Scand J Gastroenterol. 2014 Dec;49(12):1456-64
pubmed: 25283499
J Oncol. 2014;2014:767652
pubmed: 25328521
Cancer Chemother Pharmacol. 1989;23(4):255-8
pubmed: 2538252
BMC Pharmacol Toxicol. 2014 Dec 04;15:70
pubmed: 25472655
Gan To Kagaku Ryoho. 2015 Jan;42(1):57-61
pubmed: 25596680
Geriatr Gerontol Int. 2015 Jun;15(6):673-87
pubmed: 25656311
Phytother Res. 2015 Jul;29(7):1046-53
pubmed: 25857366
Anticancer Res. 2015 Apr;35(4):2199-204
pubmed: 25862878
J Clin Diagn Res. 2015 Apr;9(4):OC11-3
pubmed: 26046020
Genome Med. 2015 Jun 18;7(1):56
pubmed: 26157489
Contemp Clin Trials. 2015 Nov;45(Pt A):139-45
pubmed: 26343745
Support Care Cancer. 2016 Apr;24(4):1789-93
pubmed: 26446698
Gan To Kagaku Ryoho. 2015 Nov;42(11):1379-83
pubmed: 26602395
Cancer Chemother Pharmacol. 1989;25(1):1-9
pubmed: 2686850
Ren Fail. 2016 Jun;38(5):806-14
pubmed: 27049176
Anticancer Res. 2016 Apr;36(4):1873-7
pubmed: 27069173
Br J Cancer. 2016 Jun 14;114(12):1318-25
pubmed: 27253174
J Oncol Pharm Pract. 2017 Sep;23(6):422-428
pubmed: 27352615
Clin Exp Nephrol. 2017 Aug;21(4):732-740
pubmed: 27565169
Chin J Cancer. 2016 Sep 02;35(1):85
pubmed: 27590272
Support Care Cancer. 2017 Feb;25(2):481-487
pubmed: 27699503
Biol Pharm Bull. 2016;39(12):2009-2014
pubmed: 27904042
Support Care Cancer. 2017 Apr;25(4):1215-1220
pubmed: 27966021
J Clin Pharm Ther. 2017 Jun;42(3):286-291
pubmed: 28276070
Cancer Chemother Pharmacol. 2017 May;79(5):943-949
pubmed: 28364288
Am J Physiol Renal Physiol. 2017 Aug 1;313(2):F339-F350
pubmed: 28424213
Oncologist. 2017 May;22(5):609-619
pubmed: 28438887
J Am Coll Nutr. 2017 Jul;36(5):342-346
pubmed: 28548561
Am J Physiol Renal Physiol. 2017 Oct 1;313(4):F955-F956
pubmed: 28637790
J Nephropathol. 2017 Jul;6(3):144-149
pubmed: 28975094
J Obstet Gynaecol Res. 2017 Dec;43(12):1880-1886
pubmed: 28984058
Oncol Lett. 2018 Jan;15(1):658-664
pubmed: 29391892
J Clin Epidemiol. 2019 Jul;111:105-114
pubmed: 29432858
Cancer. 1987 Dec 1;60(11):2823-8
pubmed: 3677015
Am J Nephrol. 1985;5(6):433-6
pubmed: 3909819
Cancer Chemother Rep. 1973 Apr;57(2):191-200
pubmed: 4126381
Cancer Treat Rep. 1979 Jan;63(1):13-6
pubmed: 421230
Cancer Chemother Rep. 1973 Nov-Dec;57(4):459-63
pubmed: 4586953
Life Sci. 1983 Feb 14;32(7):685-90
pubmed: 6338333
Gynecol Oncol. 1994 Oct;55(1):82-6
pubmed: 7959273
Cancer. 1977 Apr;39(4):1372-81
pubmed: 856437
J Clin Oncol. 1996 Jul;14(7):2101-12
pubmed: 8683243
Int J Urol. 1996 Sep;3(5):343-7
pubmed: 8886909
Biol Trace Elem Res. 1997 Mar;56(3):331-41
pubmed: 9197929
Cancer Chemother Pharmacol. 1997;40(4):293-308
pubmed: 9225947
Ann Oncol. 1997 Jun;8(6):569-73
pubmed: 9261526
Eur J Clin Invest. 1997 Oct;27(10):836-9
pubmed: 9373762
Eur J Cancer. 1998 Sep;34(10):1522-34
pubmed: 9893623
Am J Med. 1978 Aug;65(2):307-14
pubmed: 99034